TGF-beta as a T cell regulator in colitis and colon cancer

Cytokine and Growth Factor Reviews

Volumn 17, Issue 1-2, 2006, Pages 97-106

  Becker, Christoph ^a   Fantini, Massimo C ^a   Neurath, Markus F ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Colitis; Colon cancer; T cells; TGF beta

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2; OVALBUMIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD7 PROTEIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1;

ANTINEOPLASTIC ACTIVITY; BIRTH; CD4+ CD25+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL FUNCTION; CELL LINE; CELL PROLIFERATION; CELL STIMULATION; CELLULAR IMMUNITY; COLITIS; COLON CANCER; COLON CARCINOGENESIS; DEATH; EFFECTOR CELL; ENTERITIS; FEEDBACK SYSTEM; GENE MUTATION; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TUMOR GROWTH; TUMOR PROMOTION;

EID: 30944466037     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2005.09.004     Document Type: Article

References (110)

1. Y. Shi, and J. Massague Mechanisms of TGF-beta signaling from cell membrane to the nucleus Cell 113 2003 685 700
2. T. Ebisawa, M. Fukuchi, G. Murakami, T. Chiba, K. Tanaka, and T. Imamura Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation J Biol Chem 276 2001 12477 12480
3. P. Kavsak, R.K. Rasmussen, C.G. Causing, S. Bonni, H. Zhu, and G.H. Thomsen Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF-beta receptor for degradation Mol Cell 6 2000 1365 1375
4. M.M. Shull, I. Ormsby, A.B. Kier, S. Pawlowski, R.J. Diebold, and M. Yin Targeted disruption of the mouse transforming growth factor-beta1 gene results in multifocal inflammatory disease Nature 359 1992 693 699
5. A.B. Kulkarni, C.G. Huh, D. Becker, A. Geiser, M. Lyght, and K.C. Flanders Transforming growth factor beta1 null mutation in mice causes excessive inflammatory response and early death Proc Natl Acad Sci USA 90 1993 770 774
6. L. Gorelik, and R.A. Flavell Abrogation of TGF-beta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease Immunity 12 2000 171 181
7. P.J. Lucas, S.J. Kim, S.J. Melby, and R.E. Gress Disruption of T cell homeostasis in mice expressing a T cell-specific dominant negative transforming growth factor beta Ii receptor J Exp Med 191 2000 1187 1196
8. A. Nakao, S. Miike, M. Hatano, K. Okumura, T. Tokuhisa, and C. Ra Blockade of transforming growth factor beta/Smad signaling in T cells by overexpression of Smad7 enhances antigen-induced airway inflammation and airway reactivity J Exp Med 192 2000 151 158
9. J.H. Kehrl, L.M. Wakefield, A.B. Roberts, S. Jakowlew, M. Alvarez-Mon, and R. Derynck Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth J Exp Med 163 1986 1037 1050
10. P. Hoehn, S. Goedert, T. Germann, S. Koelsch, S. Jin, and N. Palm Opposing effects of TGF-beta 2 on the Th1 cell development of naive CD4+ T cells isolated from different mouse strains J Immunol 155 1995 3788 3793
11. S. Sad, and T.R. Mosmann Single IL-2-secreting precursor CD4 T cell can develop into either Th1 or Th2 cytokine secretion phenotype J Immunol 153 1994 3514 3522
12. S.L. Swain, G. Huston, S. Tonkonogy, and A. Weinberg Transforming growth factor-beta and IL-4 cause helper T cell precursors to develop into distinct effector helper cells that differ in lymphokine secretion pattern and cell surface phenotype J Immunol 147 1991 2991 3000
13. G.E. Ranges, I.S. Figari, T. Espevik, and M.A. Palladino Jr. Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha J Exp Med 166 1987 991 998
14. P.E. Rao, A.L. Petrone, and P.D. Ponath Differentiation and expansion of T cells with regulatory function from human peripheral lymphocytes by stimulation in the presence of TGF-{beta} J Immunol 174 2005 1446 1455
15. S.G. Zheng, J.D. Gray, K. Ohtsuka, S. Yamagiwa, and D.A. Horwitz Generation ex vivo of TGF-beta-producing regulatory T cells from CD4+CD25- precursors J Immunol 169 2002 4183 4189
16. S. Yamagiwa, J.D. Gray, S. Hashimoto, and D.A. Horwitz A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood J Immunol 166 2001 7282 7289
17. W. Chen, W. Jin, N. Hardegen, K.J. Lei, L. Li, and N. Marinos Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3 J Exp Med 198 2003 1875 1886
18. M.C. Fantini, C. Becker, G. Monteleone, F. Pallone, P.R. Galle, and M.F. Neurath Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7 J Immunol 172 2004 5149 5153
19. M.L. Chen, M.J. Pittet, L. Gorelik, R.A. Flavell, R. Weissleder, and H. von Boehmer Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo Proc Natl Acad Sci USA 102 2005 419 424
20. R.K. Gregg, R. Jain, S.J. Schoenleber, R. Divekar, J.J. Bell, and H.H. Lee A sudden decline in active membrane-bound TGF-beta impairs both T regulatory cell function and protection against autoimmune diabetes J Immunol 173 2004 7308 7316
21. K. Nakamura, A. Kitani, and W. Strober Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta J Exp Med 194 2001 629 644
22. L. Fahlen, S. Read, L. Gorelik, S.D. Hurst, R.L. Coffman, and R.A. Flavell T cells that cannot respond to TGF-beta escape control by CD4(+)CD25(+) regulatory T cells J Exp Med 201 2005 737 746
23. G. Monteleone, F. Pallone, and T.T. MacDonald Smad7 in TGF-beta-mediated negative regulation of gut inflammation Trends Immunol 25 2004 513 517
24. R. Derynck, R.J. Akhurst, and A. Balmain TGF-beta signaling in tumor suppression and cancer progression Nat Genet 29 2001 117 129
25. L. Gorelik, and R.A. Flavell Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells Nat Med 7 2001 1118 1122
26. D.R. Morris, C.A. Kuepfer, L.R. Ellingsworth, Y. Ogawa, and P.S. Rabinovitch Transforming growth factor-beta blocks proliferation but not early mitogenic signaling events in T-lymphocytes Exp Cell Res 185 1989 529 534
27. M. Stoeck, S. Miescher, H.R. MacDonald, and V. Von Fliedner Transforming growth factors beta slow down cell-cycle progression in a murine interleukin-2 dependent T-cell line J Cell Physiol 141 1989 65 73
28. T. Brabletz, I. Pfeuffer, E. Schorr, F. Siebelt, T. Wirth, and E. Serfling Transforming growth factor beta and cyclosporin a inhibit the inducible activity of the interleukin-2 gene in T cells through a noncanonical octamer-binding site Mol Cell Biol 13 1993 1155 1162
29. L.J. Appleman, A. Berezovskaya, I. Grass, and V.A. Boussiotis CD28 costimulation mediates T cell expansion via IL-2-independent and IL-2-dependent regulation of cell cycle progression J Immunol 164 2000 144 151
30. L.J. Appleman, A.A. van Puijenbroek, K.M. Shu, L.M. Nadler, and V.A. Boussiotis CD28 costimulation mediates down-regulation of P27kip1 and cell cycle progression by activation of the Pi3k/Pkb signaling pathway in primary human T cells J Immunol 168 2002 2729 2736
31. K. Nakayama, N. Ishida, M. Shirane, A. Inomata, T. Inoue, and N. Shishido Mice lacking P27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors Cell 85 1996 707 720
32. L.A. Wolfraim, T.M. Walz, Z. James, T. Fernandez, and J.J. Letterio P21cip1 and P27kip1 act in synergy to alter the sensitivity of naive T cells to TGF-beta-mediated G1 arrest through modulation of IL-2 responsiveness J Immunol 173 2004 3093 3102
33. R.J. Coffey Jr., C.C. Bascom, N.J. Sipes, R. Graves-Deal, B.E. Weissman, and H.L. Moses Selective inhibition of growth-related gene expression in murine keratinocytes by transforming growth factor beta Mol Cell Biol 8 1988 3088 3093
34. L. Gorelik, S. Constant, and R.A. Flavell Mechanism of transforming growth factor beta-induced inhibition of T helper Type 1 differentiation J Exp Med 195 2002 1499 1505
35. C. Wu, R.R. Warrier, X. Wang, D.H. Presky, and M.K. Gately Regulation of interleukin-12 receptor beta1 chain expression and interleukin-12 binding by human peripheral blood mononuclear cells Eur J Immunol 27 1997 147 154
36. M. Afkarian, J.R. Sedy, J. Yang, N.G. Jacobson, N. Cereb, and S.Y. Yang T-Bet is a Stat1-induced regulator of IL-12r expression in naive CD4+ T cells Nat Immunol 3 2002 549 557
37. J.D. Gorham, M.L. Guler, D. Fenoglio, U. Gubler, and K.M. Murphy Low dose TGF-beta attenuates IL-12 responsiveness in murine Th cells J Immunol 161 1998 1664 1670
38. L. Ulloa, J. Doody, and J. Massague Inhibition of transforming growth factor-beta/Smad signalling by the interferon-gamma/Stat pathway Nature 397 1999 710 713
39. G.Z. Tau, T. von der Weid, B. Lu, S. Cowan, M. Kvatyuk, and A. Pernis Interferon gamma signaling alters the function of T helper Type 1 cells J Exp Med 192 2000 977 986
40. V.L. Heath, E.E. Murphy, C. Crain, M.G. Tomlinson, and A. O'Garra TGF-beta1 down-regulates Th2 development and results in decreased IL-4-induced Stat6 activation and GATA-3 expression Eur J Immunol 30 2000 2639 2649
41. L. Gorelik, P.E. Fields, and R.A. Flavell Cutting edge: TGF-beta inhibits Th Type 2 development through inhibition of GATA-3 expression J Immunol 165 2000 4773 4777
42. B.R. Ludviksson, D. Seegers, A.S. Resnick, and W. Strober The effect of TGF-beta1 on immune responses of naive versus memory CD4+ Th1/Th2 T cells Eur J Immunol 30 2000 2101 2111
43. S. Sakaguchi, N. Sakaguchi, M. Asano, M. Itoh, and M. Toda Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25) breakdown of a single mechanism of self-tolerance causes various autoimmune diseases J Immunol 155 1995 1151 1164
44. S. Sakaguchi Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self Nat Immunol 6 2005 345 352
45. F. Sallusto, D. Lenig, R. Forster, M. Lipp, and A. Lanzavecchia Two subsets of memory T lymphocytes with distinct homing potentials and effector functions Nature 401 1999 708 712
46. J.D. Gray, M. Hirokawa, and D.A. Horwitz The role of transforming growth factor beta in the generation of suppression: an interaction between CD8+ T and Nk cells J Exp Med 180 1994 1937 1942
47. S. Fu, N. Zhang, A.C. Yopp, D. Chen, M. Mao, and H. Zhang TGF-beta induces Foxp3 + T-regulatory cells from CD4+CD25- precursors Am J Transplant 4 2004 1614 1627
48. H.B. Park, D.J. Paik, E. Jang, S. Hong, and J. Youn Acquisition of anergic and suppressive activities in transforming growth factor-beta- costimulated CD4+CD25- T cells Int Immunol 16 2004 1203 1213
49. S. Huber, C. Schramm, H.A. Lehr, A. Mann, S. Schmitt, and C. Becker Cutting edge: TGF-beta signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4+CD25+ T cells J Immunol 173 2004 6526 6531
50. Y. Peng, Y. Laouar, M.O. Li, E.A. Green, and R.A. Flavell TGF-beta regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes Proc Natl Acad Sci USA 101 2004 4572 4577
51. S.P. Cobbold, R. Castejon, E. Adams, D. Zelenika, L. Graca, and S. Humm Induction of Foxp3+ regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants J Immunol 172 2004 6003 6010
52. J.C. Marie, J.J. Letterio, M. Gavin, and A.Y. Rudensky TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells J Exp Med 201 2004 1061 1067
53. C. Schramm, S. Huber, M. Protschka, P. Czochra, J. Burg, and E. Schmitt TGF-beta regulates the CD4+CD25+ T-cell pool and the expression of Foxp3 in vivo Int Immunol 16 2004 1241 1249
54. R.M. Gorczynski, L. Lee, and I. Boudakov Augmented induction of CD4+CD25+ Treg using monoclonal antibodies to CD200r Transplantation 79 2005 1180 1183
55. X. Luo, H. Yang, I.S. Kim, F. Saint-Hilaire, D.A. Thomas, and B.P. De Systemic transforming growth factor-beta1 gene therapy induces Foxp3+ regulatory cells, restores self-tolerance, and facilitates regeneration of beta cell function in overtly diabetic nonobese diabetic mice Transplantation 79 2005 1091 1096
56. S.G. Zheng, J.H. Wang, M.N. Koss, F. Quismorio Jr., J.D. Gray, and D.A. Horwitz CD4+ and CD8+ regulatory T cells generated ex vivo with IL-2 and TGF-beta suppress a stimulatory graft-versus-host disease with a Lupus-like syndrome J Immunol 172 2004 1531 1539
57. A. Nakao, M. Afrakhte, A. Moren, T. Nakayama, J.L. Christian, and R. Heuchel Identification of Smad7, a TGF-beta-inducible antagonist of TGF-beta signalling Nature 389 1997 631 635
58. T. Mizobuchi, K. Yasufuku, Y. Zheng, M.A. Haque, K.M. Heidler, and K. Woods Differential expression of Smad7 transcripts identifies the CD4+CD45rc high regulatory T cells that mediate Type V collagen-induced tolerance to lung allografts J Immunol 171 2003 1140 1147
59. S. Zelenay, T. Lopes-Carvalho, I. Caramalho, M.F. Moraes-Fontes, M. Rebelo, and J. Demengeot Foxp3+ CD25-CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion Proc Natl Acad Sci USA 102 2005 4091 4096
60. C.A. Piccirillo, J.J. Letterio, A.M. Thornton, R.S. McHugh, M. Mamura, and H. Mizuhara CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness J Exp Med 196 2002 237 246
61. A. Rosendahl, M. Speletas, K. Leandersson, F. Ivars, and P. Sideras Transforming growth factor-beta- and activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis Int Immunol 15 2003 1401 1414
62. H. Schluesener, S. Jung, and M. Salvetti Susceptibility and resistance of human autoimmune T cell activation to the immunoregulatory effects of transforming growth factor (TGF) beta 1, beta 2, and beta 1.2 J Neuroimmunol 28 1990 271 276
63. Y.Y. Wan, and R.A. Flavell Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter Proc Natl Acad Sci USA 102 2005 5126 5131
64. A.M. Thornton, and E.M. Shevach CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production J Exp Med 188 1998 287 296
65. M.K. Levings, R. Sangregorio, and M.G. Roncarolo Human CD25(+)CD4(+) T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function J Exp Med 193 2001 1295 1302
66. S. Read, S. Mauze, C. Asseman, A. Bean, R. Coffman, and F. Powrie CD38+ CD45rb(low) CD4+ T cells: a population of T cells with immune regulatory activities in vitro Eur J Immunol 28 1998 3435 3447
67. L.A. Stephens, C. Mottet, D. Mason, and F. Powrie Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro Eur J Immunol 31 2001 1247 1254
68. L.S. Taams, J. Smith, M.H. Rustin, M. Salmon, L.W. Poulter, and A.N. Akbar Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population Eur J Immunol 31 2001 1122 1131
69. H. Jonuleit, E. Schmitt, M. Stassen, A. Tuettenberg, J. Knop, and A.H. Enk Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood J Exp Med 193 2001 1285 1294
70. D. Dieckmann, H. Plottner, S. Berchtold, T. Berger, and G. Schuler Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood J Exp Med 193 2001 1303 1310
71. W.F. Ng, P.J. Duggan, F. Ponchel, G. Matarese, G. Lombardi, and A.D. Edwards Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells Blood 98 2001 2736 2744
72. K. Nakamura, A. Kitani, I. Fuss, A. Pedersen, N. Harada, and H. Nawata TGF-beta1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice J Immunol 172 2004 834 842
73. K. Bachmaier, C. Krawczyk, I. Kozieradzki, Y.Y. Kong, T. Sasaki, and A. Oliveira-dos-Santos Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-B Nature 403 2000 211 216
74. Y.J. Chiang, H.K. Kole, K. Brown, M. Naramura, S. Fukuhara, and R.J. Hu Cbl-B regulates the CD28 dependence of T-cell activation Nature 403 2000 216 220
75. E.A. Wohlfert, M.K. Callahan, and R.B. Clark Resistance to CD4+CD25+ regulatory T cells and TGF-beta in Cbl-B-/- mice J Immunol 173 2004 1059 1065
76. J.J. Letterio, A.G. Geiser, A.B. Kulkarni, N.S. Roche, M.B. Sporn, and A.B. Roberts Maternal rescue of transforming growth factor-beta1 null mice Science 264 1994 1936 1938
77. A.M. Mowat Anatomical basis of tolerance and immunity to intestinal antigens Nat Rev Immunol 3 2003 331 341
78. I.J. Fuss, M. Boirivant, B. Lacy, and W. Strober The interrelated roles of TGF-beta and IL-10 in the regulation of experimental colitis J Immunol 168 2002 900 908
79. M.F. Neurath, I. Fuss, B.L. Kelsall, D.H. Presky, W. Waegell, and W. Strober Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance J Exp Med 183 1996 2605 2616
80. K.M. Thorstenson, and A. Khoruts Generation of anergic and potentially immunoregulatory CD25+CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen J Immunol 167 2001 188 195
81. X. Zhang, L. Izikson, L. Liu, and H.L. Weiner Activation of CD25(+)CD4(+) regulatory T cells by oral antigen administration J Immunol 167 2001 4245 4253
82. Y. Chung, S.H. Lee, D.H. Kim, and C.Y. Kang Complementary role of CD4+CD25+ regulatory T cells and TGF-{beta} in oral tolerance J Leukoc Biol 77 2005 906 913
83. D. Mucida, N. Kutchukhidze, A. Erazo, M. Russo, J.J. Lafaille, and M.A. Curotto de Lafaille Oral tolerance in the absence of naturally occurring Tregs J Clin Invest 2005
84. P.A. Gonnella, Y. Chen, J. Inobe, Y. Komagata, M. Quartulli, and H.L. Weiner In situ immune response in gut-associated lymphoid tissue (galt) following oral antigen in Tcr-transgenic mice J Immunol 160 1998 4708 4718
85. W. Chen, and S.M. Wahl TGF-beta: the missing link in CD4+CD25+ regulatory T cell-mediated immunosuppression Cytokine Growth Factor Rev 14 2003 85 89
86. X. Yang, J.J. Letterio, R.J. Lechleider, L. Chen, R. Hayman, and H. Gu Targeted disruption of Smad3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta EMBO J 18 1999 1280 1291
87. G. Monteleone, A. Kumberova, N.M. Croft, C. McKenzie, H.W. Steer, and T.T. MacDonald Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease J Clin Invest 108 2001 601 609
88. M.W. Babyatsky, G. Rossiter, and D.K. Podolsky Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease Gastroenterology 110 1996 975 984
89. G. Monteleone, G. Del Vecchio Blanco, G. Palmieri, P. Vavassori, I. Monteleone, and A. Colantoni Induction and regulation of Smad7 in the gastric mucosa of patients with Helicobacter pylori infection Gastroenterology 126 2004 674 682
90. S. Makita, T. Kanai, S. Oshima, K. Uraushihara, T. Totsuka, and T. Sawada CD4+CD25 bright T cells in human intestinal lamina propria as regulatory cells J Immunol 173 2004 3119 3130
91. S.A. Rosenberg Progress in human tumour immunology and immunotherapy Nature 411 2001 380 384
92. C. Becker, M.C. Fantini, C. Schramm, H.A. Lehr, S. Wirtz, and A. Nikolaev TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling Immunity 21 2004 491 501
93. C. Becker, M.C. Fantini, S. Wirtz, A. Nikolaev, H.A. Lehr, and P.R. Galle IL-6 signaling promotes tumor growth in colorectal cancer Cell Cycle 4 2005 217 220
94. R.P. Sutmuller, L.M. van Duivenvoorde, A. van Elsas, T.N. Schumacher, M.E. Wildenberg, and J.P. Allison Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses J Exp Med 194 2001 823 832
95. J. Shimizu, S. Yamazaki, and S. Sakaguchi Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity J Immunol 163 1999 5211 5218
96. S. Onizuka, I. Tawara, J. Shimizu, S. Sakaguchi, T. Fujita, and E. Nakayama Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody Cancer Res 59 1999 3128 3133
97. E. Jones, M. Dahm-Vicker, A.K. Simon, A. Green, F. Powrie, and V. Cerundolo Depletion of CD25+ regulatory cells results in suppression of melanoma growth and induction of autoreactivity in mice Cancer Immun 2 2002 1
98. M. Reiss, and M.H. Barcellos-Hoff Transforming growth factor-beta in breast cancer: a working hypothesis Breast Cancer Res Treat 45 1997 81 95
99. R. Baillie, R.C. Coombes, and J. Smith Multiple forms of TGF-beta1 in breast tissues: a biologically active form of the small latent complex of TGF-beta1 Eur J Cancer 32A 1996 1566 1573
100. E. Friedman, L.I. Gold, D. Klimstra, Z.S. Zeng, S. Winawer, and A. Cohen High levels of transforming growth factor beta1 correlate with disease progression in human colon cancer Cancer Epidemiol Biomarkers Prev 4 1995 549 554
101. J.A. Reed, N.S. McNutt, V.G. Prieto, and A.P. Albino Expression of transforming growth factor-beta 2 in malignant melanoma correlates with the depth of tumor invasion implications for tumor progression Am J Pathol 145 1994 97 104
102. K. Matsuzaki, M. Date, F. Furukawa, Y. Tahashi, M. Matsushita, and K. Sakitani Autocrine stimulatory mechanism by transforming growth factor beta in human hepatocellular carcinoma Cancer Res 60 2000 1394 1402
103. S.J. Kim, Y.H. Im, S.D. Markowitz, and Y.J. Bang Molecular mechanisms of inactivation of TGF-beta receptors during carcinogenesis Cytokine Growth Factor Rev 11 2000 159 168
104. W.M. Grady, L.L. Myeroff, S.E. Swinler, A. Rajput, S. Thiagalingam, and J.D. Lutterbaugh Mutational inactivation of transforming growth factor beta receptor type Ii in microsatellite stable colon cancers Cancer Res 59 1999 320 324
105. M. Hoefer, and F.A. Anderer Anti-(transforming growth factor beta) antibodies with predefined specificity inhibit metastasis of highly tumorigenic human xenotransplants in Nu/Nu mice Cancer Immunol Immunother 41 1995 302 308
106. P. Yu, Y. Lee, W. Liu, T. Krausz, A. Chong, and H. Schreiber Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors J Exp Med 201 2005 779 791
107. S.E. Erdman, T. Poutahidis, M. Tomczak, A.B. Rogers, K. Cormier, and B. Plank CD4+CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice Am J Pathol 162 2003 691 702
108. S.E. Erdman, V.P. Rao, T. Poutahidis, M.M. Ihrig, Z. Ge, and Y. Feng CD4(+)CD25(+) regulatory lymphocytes require interleukin 10 to interrupt colon carcinogenesis in mice Cancer Res 63 2003 6042 6050
109. L.K. Su, K.W. Kinzler, B. Vogelstein, A.C. Preisinger, A.R. Moser, and C. Luongo Multiple intestinal neoplasia caused by a mutation in the murine homolog of the Apc gene Science 256 1992 668 670
110. S.E. Erdman, J.J. Sohn, V.P. Rao, P.R. Nambiar, Z. Ge, and J.G. Fox CD4+CD25+ regulatory lymphocytes induce regression of intestinal tumors in Apcmin/+ mice Cancer Res 65 2005 3998 4004